AGF U.S. Market Neutral Anti-Beta Fund (NYSEARCA:BTAL – Get Free Report) was the target of a large decline in short interest during the month of June. As of June 15th, there was short interest totaling 501,655 shares, a decline of 61.5% from the May 31st total of 1,303,551 shares. Approximately 2.0% of the company’s stock are short sold. Based on an average daily volume of 754,759 shares, the short-interest ratio is currently 0.7 days.
Institutional Inflows and Outflows
Hedge funds have recently modified their holdings of the stock. Crescent Grove Advisors LLC purchased a new stake in AGF U.S. Market Neutral Anti-Beta Fund in the 1st quarter valued at $6,614,000. Bank of New York Mellon Corp boosted its holdings in AGF U.S. Market Neutral Anti-Beta Fund by 59.4% during the 1st quarter. Bank of New York Mellon Corp now owns 27,235 shares of the company’s stock worth $380,000 after acquiring an additional 10,146 shares during the last quarter. Worth Asset Management LLC boosted its holdings in AGF U.S. Market Neutral Anti-Beta Fund by 20.5% during the 1st quarter. Worth Asset Management LLC now owns 30,472 shares of the company’s stock worth $425,000 after acquiring an additional 5,190 shares during the last quarter. PMV Capital Advisers LLC grew its stake in shares of AGF U.S. Market Neutral Anti-Beta Fund by 14.0% in the 1st quarter. PMV Capital Advisers LLC now owns 246,621 shares of the company’s stock worth $3,443,000 after acquiring an additional 30,234 shares in the last quarter. Finally, Advisory Services Network LLC grew its stake in shares of AGF U.S. Market Neutral Anti-Beta Fund by 2,091.7% in the 4th quarter. Advisory Services Network LLC now owns 329,604 shares of the company’s stock worth $4,743,000 after acquiring an additional 314,565 shares in the last quarter.
AGF U.S. Market Neutral Anti-Beta Fund Stock Performance
Shares of BTAL opened at $11.37 on Friday. The stock has a 50 day moving average price of $11.90 and a two-hundred day moving average price of $13.31. The firm has a market capitalization of $292.21 million, a P/E ratio of 17.67 and a beta of -0.63. AGF U.S. Market Neutral Anti-Beta Fund has a 52 week low of $10.86 and a 52 week high of $18.09.
About AGF U.S. Market Neutral Anti-Beta Fund
The AGFiQ U.S. Market Neutral Anti-Beta Fund (BTAL) is an exchange-traded fund that mostly invests in long\u002Fshort alternatives. The fund is an actively managed fund that takes long positions in low beta US stocks, offset by short positions in high beta US stocks. BTAL was launched on Sep 13, 2011 and is managed by AGF.
Recommended Stories
- Five stocks we like better than AGF U.S. Market Neutral Anti-Beta Fund
- Capri’s Turnaround Is Taking Shape, But Is the Stock a Buy Yet?
- SpaceX Has Real Value—But These 3 Stocks Have Better Odds Right Now
- 3 Stocks That Could Benefit as the Robotaxi Race Heats Up
- 3 Waste Stocks Turning AI Investments into Growth
Receive News & Ratings for AGF U.S. Market Neutral Anti-Beta Fund Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AGF U.S. Market Neutral Anti-Beta Fund and related companies with MarketBeat.com's FREE daily email newsletter.
